While the National Institutes of Health (NIH) and the National Science Foundation (NSF) have voiced caution and funded efforts to understand the potential societal and environmental implications of nanotechnology deployment, both agencies announced much larger funding commitments - totaling $213 million - to expedite commercial applications for the explosive field.

Nanotech Solutions for Cancer

More than half since recession "officially" ended

There is little comforting news in a new statistical report for workers in the U.S. information and communication technologies (ICT) sector. Researchers from the University of Illinois-Chicago found the sector lost 403,300 jobs between March 2001 and April 2004.

As part of a new initiative to address pressing ethical, legal and social questions raised by recent advances in genetic and genomic research, the National Human Genome Research Institute (NHGRI) has awarded approximately $20 million in grants to fund interdisciplinary centers within universities around the country over the next five years. NHGRI is one of the National Institutes of Health (NIH).

New York City Launches Second Biotech Incubator Companies wanting to commercialize new technologies can now bring their companies to Brooklyn, with the June opening of a new technology incubator located near Downstate University's biochemistry department.

The National Institutes of Health (NIH), the largest federal funding source for life sciences research conducted by small tech firms, has selected the Larta Institute to manage its nationwide Commercialization Assistance Program. The multi-year $2.5 million award will target Phase II recipients of the NIH Small Business Innovation Research and Small Business Technology Transfer Programs (SBIR/STTR).

NBIA Releases Revised Business Incubation Guide

Real estate developer Robert Klein II was selected as chairman of California's stem cell oversight committee.

One of the biggest obstacles for products drawing on alternative energy is finding a market big enough to bring the cost down of their new technologies to attract the larger more risk-adverse population of consumers. Californians are stepping up to the challenge after committing to invest nearly $3 billion over the next 10 years to aid in the shift to cleaner power.

The University of California (UC) is demonstrating success in several key areas under a compact designed to facilitate timely graduation. Findings of the first annual report reveal the university is achieving success in degree production in high priority areas for the state, effective community college transfer, and transfer of research innovations to the marketplace, according to the UC press office.

Foundations and philanthropists are playing increasingly important financial roles for many academic and regional technology-based economic development (TBED) efforts. The latest issue of Philanthropy News Digest, the weekly electronic newsletter of the FoundationCenter, highlights three recent announcements that provide examples of the size, scope and opportunity presented by these types of awards. The announcements are summarized below.

For many university tech transfer operations, the need to generate revenues to support the office and attempt to meet the often pie-in-the-sky expectations of school administrators can force licensing efforts toward only the biggest deals. Thanks to a large donation to serve as an endowment, the University of Southern California (USC) Viterbi School of Engineering will be able to count on $1 million in interest income to support its technology transfer activities.

Dr. John Reed, president and CEO of The Burnham Institute, was appointed to the Independent Citizen's Oversight Committee that will govern the California Institute for Regenerative Medicine created last month.

Just as SSTI and other post-election analysts predicted, California’s recent passage of a $3 billion commitment to stem cell research is triggering responses from across the country. Wisconsin is the first to outline a specific, strategic reaction to the California referendum in an effort to retain or regain momentum in the race to encourage bio-based economic growth.

West Virginia University’s plan to develop strong research capabilities in a number of focused areas, creating hundreds of new jobs, may be completed in half the time originally anticipated. Gov. Bob Wise announced last week a $24.4 million funding package to jump-start the implementation of new research facilities and laboratories on the WVU campus.

Using data from its 2004 Best Performing Cities Index, Milken has generated a comprehensive table ranking cities by one- and five-year measurements of job growth, wages and salaries, and relative high tech gross domestic product (GDP) growth, and other measurements.

Implementation of the Global Grid Exchange, a state-sponsored open public computing grid in West Virginia, is underway. Hewlett Packard will provide the infrastructure technology that will power the grid, an initiative of the West Virginia High Technology Consortium (WVHTC) Foundation.

What policies, investments and programs would be most effective for communities trying to attract, retain or build a local pharmaceutical industry? Research parks? Tax incentives? Biotech seed capital funds?

Duane Roth is the new executive director of UCSD CONNECT. Roth was CEO of Alliance Pharmaceuticals in San Diego.

Last year, nearly 17 million international passengers passed through Los Angeles International Airport (LAX). Many of those passengers were businesspeople who rely on convenient access to international flights to keep their companies in touch with partners, customers, divisions and markets all over the world. International flights out of LAX have played a key role in positioning the Los Angeles region as the largest manufacturing center in the U.S. and as a national high-tech leader.

California

Richard Murphy was named interim president of the California Institute of Regenerative Medicine (CIRM). Arlene Chiu announced she will resign as interim chief scientific officer of CIRM, effective Oct. 31.